Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026)

Enovis' (ENOV) quarterly Net Income towards Common Stockholders came in at -$39000.0 in Q2 2026, up 68.8% year-on-year from -$23104.3 in Q2 2025, and up 97.64% on a QoQ basis from -$1.7 million in Q4 2025.

Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$39000.0 in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 68.8% year-over-year to -$39000.0 in Q2 2026; TTM through Apr 2026 was -$1.8 million, a 173.63% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 173.39% from the prior year.
  • Net Income towards Common Stockholders for Q2 2026 stood at -$39000.0, up from -$1.7 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ENOV reached as high as $16.6 million in Q3 2023 and fell as low as -$43.7 million in Q3 2022.
  • Historically, Net Income towards Common Stockholders has averaged $556437.5 across 5 years, with a median of -$39500.0 in 2025.
  • Across the five-year window, Net Income towards Common Stockholders surged 3450.0% in 2024 and slumped 487.56% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $16.3 million in 2022, then slumped by 99.93% to $12000.0 in 2023, then jumped by 3450.0% to $426000.0 in 2024, then slumped by 487.56% to -$1.7 million in 2025, then surged by 97.64% to -$39000.0 in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$39000.0 in Q2 2026, -$1.7 million in Q4 2025, and -$40000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Enovis 1.61 Bn 1.58 Bn 365.49 Mn -39,000.00

Historic Data

Download Data
DateValue
Apr 3, 2026 -39,000.00
Dec 31, 2025 -1.65 Mn
Oct 3, 2025 -40,000.00
Jul 4, 2025 -93,000.00
Apr 4, 2025 -125,000.00
Dec 31, 2024 426,000.00
Sep 27, 2024 2.24 Mn
Jun 28, 2024 -68,000.00
Dec 31, 2023 12,000.00
Sep 29, 2023 16.61 Mn
Jun 30, 2023 4.80 Mn
Mar 31, 2023 -312,000.00
Dec 31, 2022 16.27 Mn
Sep 30, 2022 -527,000.00
Jul 1, 2022 -43.67 Mn
Apr 1, 2022 15.07 Mn
Dec 31, 2021 14.17 Mn
Oct 1, 2021 25.85 Mn
Jul 2, 2021 28.64 Mn
Apr 2, 2021 19.07 Mn